Your last statement Onestpeahead is the most significant aspect about CYDY in terms of an investment, in my opinion. After investing in stocks for some decades, it is very rare to see a company that is just starting on what could be an incredible road...something that could be life changing for an investor. Yes, there is nothing approved, lots of anectodal evidence but nothing yet where the powers that be (the FDA) says "Data great, it's everything you've been suggesting, you're APPROVED to sell your product." And that's why we're still here at $6-$7. But when one looks at the available data, the Mechanism of Action that is basically undeniable at this point, the number of potential uses for a growing list of diseases...it is very difficult for me to comprehend how any investor would not also look at it all and decide this little company could start to dominate the pharma universe, and that equals a life changing investment.
GLTA
To The Moon Alice